From Our Writers

Two recent, separately published surveys suggest that the coronavirus pandemic has shifted both how people get their cannabis and the reasons for their cannabis use.

A New Mexico district court judge ruled this week that the Department of Health is not allowed to deny medical cannabis program reciprocity for out-of-state patients.

Illinois cannabis tax revenues outpaced alcohol tax revenues for the first time after generating $86 million during the year’s first quarter.

The FDA has announced plans to ban flavored tobacco products including menthol cigarettes and flavored cigars.

Washington’s new cannabis social equity provisions, which will offer grant funding and expert advice for qualifying individuals, were signed into law on Monday.

New Mexico’s health department has revoked the license of cannabis company New MexiCann Natural Medicine after an accident last year left two employees seriously injured.

The U.S. Supreme Court declined to hear an appeal case brought by California cannabis companies seeking to challenge their severe tax bills under Section 280E due to delayed paperwork.

The New York City Taxi & Limousine Commission will stop testing drivers for cannabis after New York legalized cannabis for adult use in March.

The Health Commission of Switzerland’s National Council voted 13-11 last week in favor of federally legalizing cannabis for all adults.

The Massachusetts Department of Agricultural Resources is granting hemp and cannabis farmers access to 73,000 acres of protected farmland in the state. The land was preserved for future agricultural use under a program established in 1979.

Canadian cannabis companies Tilray and Aphria have finished their merger to become the world’s largest cannabis company based on pro forma revenue.

Maryland police can no longer stop and search people based on perceived cannabis odors following a Maryland appeals court ruling.

Washington’s legislation to reestablish drug possession penalties after a February Supreme Court decision decriminalized all drugs has been approved and now awaits Gov. Inslee’s signature.

UK-based GW Pharmaceuticals — the manufacturer of Epidiolex, the first FDA-approved cannabis medication — was awarded the Queen’s Award for Enterprise 2021 in the Innovation category.

A proposal in Maine is seeking to legalize psilocybin mushroom therapy for anyone aged 21 or older.

South Dakota’s Supreme Court heard arguments on Wednesday in the governor’s legal challenge to the cannabis legalization ballot initiative that was approved by last November.

Washington regulators issued a policy statement this week clarifying that Delta-8 THC products are not legal under the state’s cannabis regulations.

Oklahoma has paused the implementation of its seed-to-sale tracking system due to a lawsuit filed by multiple medical cannabis businesses claiming the system would allow for a monopoly.

Phillip Morris, the maker of Marlboro cigarettes, is reportedly considering a smoke-free entrance to the cannabis space.

The Texas House approved expansions to the state’s medical cannabis program that would raise the THC limit from 0.5% to 5% and legalize access for patients with chronic pain, PTSD, and cancer.

Philadelphia’s City Council has banned pre-employment drug screenings for cannabis by most businesses in the city.

Syracuse University announced a partnership with the cannabis education platform Green Flower to provide an online industry certificate program.

At least six financial institutions are currently serving Massachusetts-based cannabusinesses — double the number from just three years ago.

Louisiana’s cannabis legalization proposal has cleared its final committee before heading to the House floor for consideration.